Literature DB >> 23043226

Effects of μ-opioid receptor modulation on the hippocampal network activity of sharp wave and ripples.

Panagiotis Giannopoulos1, Costas Papatheodoropoulos.   

Abstract

BACKGROUND AND
PURPOSE: Hippocampus-dependent memory involves the activity of sharp wave ripples (SWRs), which are thought to participate in the process of memory consolidation. The hippocampus contains high levels of endogenous opioids and of μ-opioid receptors (MORs). Here, we have assessed the role of MOR agonists in the modulation of SWRs. EXPERIMENTAL APPROACH: Using recordings of extracellular potentials from the CA1 field of rat hippocampal slices, we examined the pharmacological actions of morphine, DAMGO and fentanyl on SWRs and on network excitability and paired-pulse inhibition. KEY
RESULTS: All three MOR agonists (1 nM-10 μM) significantly increased the amplitude of sharp waves and the occurrence of SWR sequences, but reduced the initiation of episodes of SWRs. Fentanyl was most potent in producing these effects and morphine the least. Interestingly, although SWRs were reduced by relatively high concentrations (≥100 nM) of all agonists, they were significantly enhanced by very low concentrations of morphine (5-10 nM). Morphine and DAMGO at moderate-to-high concentrations increased network excitability and reduced inhibition. Furthermore, DAMGO suppressed inhibition more readily than it increased excitation, whereas morphine suppressed inhibition only at high concentrations. These drug effects were reversed by the MOR antagonists naloxone and CTOP. CONCLUSIONS AND IMPLICATIONS: We found that the SWRs were significantly modulated by three MOR agonists and that the SWRs were very sensitive to subtle changes in the excitation/inhibition balance induced by MOR agonists. Such modulation might underlie the effects of these agonists on hippocampus-dependent memory.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23043226      PMCID: PMC3594674          DOI: 10.1111/j.1476-5381.2012.02240.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  93 in total

1.  Selective suppression of hippocampal ripples impairs spatial memory.

Authors:  Gabrielle Girardeau; Karim Benchenane; Sidney I Wiener; György Buzsáki; Michaël B Zugaro
Journal:  Nat Neurosci       Date:  2009-09-13       Impact factor: 24.884

2.  Coexpression of the mu-opioid receptor splice variant MOR1C and the vesicular glutamate transporter 2 (VGLUT2) in rat central nervous system.

Authors:  Stephen A Schnell; Martin W Wessendorf
Journal:  J Comp Neurol       Date:  2008-06-01       Impact factor: 3.215

3.  Hippocampal replay of extended experience.

Authors:  Thomas J Davidson; Fabian Kloosterman; Matthew A Wilson
Journal:  Neuron       Date:  2009-08-27       Impact factor: 17.173

4.  Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study.

Authors:  Minh P Lam; Peter W Marinelli; Li Bai; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2008-08-08       Impact factor: 4.530

5.  Layer selective presynaptic modulation of excitatory inputs to hippocampal cornu Ammon 1 by mu-opioid receptor activation.

Authors:  A R McQuiston
Journal:  Neuroscience       Date:  2007-10-11       Impact factor: 3.590

6.  Ivy cells: a population of nitric-oxide-producing, slow-spiking GABAergic neurons and their involvement in hippocampal network activity.

Authors:  Pablo Fuentealba; Rahima Begum; Marco Capogna; Shozo Jinno; László F Márton; Jozsef Csicsvari; Alex Thomson; Peter Somogyi; Thomas Klausberger
Journal:  Neuron       Date:  2008-03-27       Impact factor: 17.173

7.  Augmented hippocampal ripple oscillations in mice with reduced fast excitation onto parvalbumin-positive cells.

Authors:  Attila Rácz; Alexey A Ponomarenko; Elke C Fuchs; Hannah Monyer
Journal:  J Neurosci       Date:  2009-02-25       Impact factor: 6.167

8.  State-dependent spike-timing relationships between hippocampal and prefrontal circuits during sleep.

Authors:  Casimir M Wierzynski; Evgueniy V Lubenov; Ming Gu; Athanassios G Siapas
Journal:  Neuron       Date:  2009-02-26       Impact factor: 17.173

9.  Rhythmically active enkephalin-expressing GABAergic cells in the CA1 area of the hippocampus project to the subiculum and preferentially innervate interneurons.

Authors:  Pablo Fuentealba; Ryohei Tomioka; Yannis Dalezios; László F Márton; Michele Studer; Kathleen Rockland; Thomas Klausberger; Peter Somogyi
Journal:  J Neurosci       Date:  2008-10-01       Impact factor: 6.167

10.  Hippocampal sharp wave/ripples during sleep for consolidation of associative memory.

Authors:  Wiâm Ramadan; Oxana Eschenko; Susan J Sara
Journal:  PLoS One       Date:  2009-08-20       Impact factor: 3.240

View more
  5 in total

Review 1.  Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning.

Authors:  György Buzsáki
Journal:  Hippocampus       Date:  2015-10       Impact factor: 3.899

Review 2.  Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu-opioid receptor.

Authors:  Jia-Jia Zhang; Chang-Geng Song; Ji-Min Dai; Ling Li; Xiang-Min Yang; Zhi-Nan Chen
Journal:  MedComm (2020)       Date:  2022-06-22

3.  Cross State-dependent Learning Interaction Between Scopolamine and Morphine in Mice: The Role of Dorsal Hippocampus.

Authors:  Morteza Maleki; Majid Hassanpour-Ezatti; Majid Navaeian
Journal:  Basic Clin Neurosci       Date:  2017 May-Jun

4.  Effect of acute fentanyl treatment on synaptic plasticity in the hippocampal CA1 region in rats.

Authors:  Hai Tian; Yueming Xu; Fucun Liu; Guowei Wang; Sanjue Hu
Journal:  Front Pharmacol       Date:  2015-10-30       Impact factor: 5.810

5.  Higher intrinsic network excitability in ventral compared with the dorsal hippocampus is controlled less effectively by GABAB receptors.

Authors:  Costas Papatheodoropoulos
Journal:  BMC Neurosci       Date:  2015-11-10       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.